Drug Trial Radar · NCT03850782
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
515
Actual
Start
Feb 28, 2019
Primary completion
Aug 8, 2025
Study completion Aug 8, 2025
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Feb 22, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the duration of intraocular pressure (IOP)-lowering effect and safety of as needed administrations of Bimatoprost sustained release (SR) in participants with open-angle glaucoma (OAG) or ocular hypertension (OHT) who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy.
Conditions
- Open-Angle Glaucoma
- Ocular Hypertension
Interventions
Bimatoprost (SR)Drug
Study Eye: Cycles 1 - 3 administrations through the PRN treatment period. Fellow Eye: Standard of care or Bimatoprost SR.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Retreatment or Rescue Administered for Intraocular Pressure (IOP)Time frame: Up to 48 months
- Probability of Not Receiving Second Administration or RescueTime frame: Up to 48 months
- Number of Patients Experiencing a Treatment Emergent Adverse Event (TEAE)Time frame: Baseline up to 48 months
Locations
108 sites in 16 countries. Site status is shown where the registry gives one.
Horizon Eye Specialists & Lasik Centers /ID# 235240
Sun City, Arizona
Atlantis Eye Care /ID# 235530
Huntington Beach, California
Lakeside Vision Center /ID# 234970
Irvine, California
Global Research Foundation /ID# 237350
Los Angeles, California
The Eye Research Foundation /ID# 234521
Newport Beach, California
Byers Eye Institute Stanford /ID# 235544
Palo Alto, California
Foothill Eye Institute /ID# 235640
Pasadena, California
Connecticut Eye Consultants P.C. /ID# 234981
Danbury, Connecticut
Advanced Research, LLC /ID# 236045
Deerfield Beach, Florida
Segal Drug Trials, Inc /ID# 235784
Delray Beach, Florida
International Research Center /ID# 238050
Tampa, Florida
Thomas Eye Group PC /ID# 235737
Sandy Springs, Georgia
Indiana University - Glick Eye Institute /ID# 235886
Indianapolis, Indiana
Retina Partners Midwest, PC /ID# 237876
Indianapolis, Indiana
Tulane University School of Medicine /ID# 237632
New Orleans, Louisiana
Ophthalmic Consultants of Boston /ID# 236534
Boston, Massachusetts
Clinical Eye Research of Boston LLC /ID# 234966
Winchester, Massachusetts
University of Michigan, Kellogg Eye Center /ID# 236496
Ann Arbor, Michigan
Fraser Eye Center /ID# 235790
Fraser, Michigan
Silverstein Eye Centers /ID# 237881
Kansas City, Missouri
Moyes Eye Centers /ID# 234989
Kansas City, Missouri
Alterman Modi & Wolter /ID# 235248
Poughkeepsie, New York
The Ohio State University /ID# 236790
Columbus, Ohio
AMA Eyes Research Institute /ID# 235542
Marysville, Ohio
Dean McGee Eye Institute /ID# 236823
Oklahoma City, Oklahoma
Oklahoma Eye Surgeons /ID# 235849
Oklahoma City, Oklahoma
Drs Fine Hoffman & Sims LLC /ID# 235918
Eugene, Oregon
Ophthalmic Partners, PC /ID# 235741
Bala-Cynwyd, Pennsylvania
Scott and Christie and Associates /ID# 234593
Cranberry Township, Pennsylvania
Black Hills Regional Eye Institute /ID# 235075
Rapid City, South Dakota
Vance Thompson Vision /ID# 235072
Sioux Falls, South Dakota
Eye Specialty Group /ID# 235721
Memphis, Tennessee
Vanderbilt University Medical Center /ID# 237177
Nashville, Tennessee
Advancing Vision Research /ID# 236681
Smyrna, Tennessee
ATX Clinical Trials Inc. dba Keystone Research /ID# 235868
Austin, Texas
Medical Center Ophthalmology Associates - Keystone Research /ID# 235787
San Antonio, Texas
Southern Utah Medical Research /ID# 235602
St. George, Utah
Piedmont Eye Center /ID# 234534
Lynchburg, Virginia
Hospital Italiano /ID# 235851
Buenos Aires, Argentina
Centro Privado de Ojos /ID# 241283
Ciudad Autonoma Buenos Aires, Argentina
Showing 40 of 108 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.